about
Kappa opioid antagonists: past successes and future prospectsDesign, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.7α-Methoxy-carbonyl-6,7,8,14-tetra-hydro-6,14-endo-ethenothebaine.Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsA Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mBinding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.
P2860
Q24647830-78085EB5-86CB-4BC2-9357-ADBEE4424183Q33893723-57471647-0EB2-42FB-8D68-6ED681F4E77DQ34263220-576B79B8-A999-4E2D-A61F-6F6933358B29Q34583511-BFABC9F1-0349-40BB-A42E-FF2FB470AF39Q35220086-FCEE92E7-B866-4415-92AE-F6B7A76ACD4CQ36015414-88ECFC69-51D5-422A-B401-A32BD56C63BFQ36404602-33C2247F-CD71-48ED-A7E9-374B104F8F74Q36839084-EF4FBA04-7284-4045-ABDE-ED2371A7C4C0Q37317909-D4DF30AF-6272-4F87-A453-2785A021944CQ38743944-11C58AEF-6FDD-43A5-B012-1E8242E7E8AFQ42942034-F30D071B-C86C-4E6A-ACD6-72E0D051C6F5Q43117967-A3312774-411F-40E2-81AE-83EB0C6F93B5
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Opioid receptor antagonists.
@ast
Opioid receptor antagonists.
@en
type
label
Opioid receptor antagonists.
@ast
Opioid receptor antagonists.
@en
prefLabel
Opioid receptor antagonists.
@ast
Opioid receptor antagonists.
@en
P1476
Opioid receptor antagonists.
@en
P2093
Schmidhammer H
P304
P577
1998-01-01T00:00:00Z